Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$39.41 - $47.25 $492,427 - $590,388
-12,495 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$43.34 - $65.91 $7,974 - $12,127
-184 Reduced 1.45%
12,495 $554,000
Q4 2020

Feb 16, 2021

BUY
$23.3 - $59.57 $295,420 - $755,288
12,679 New
12,679 $695,000
Q3 2020

Nov 13, 2020

SELL
$20.5 - $28.59 $451,000 - $628,980
-22,000 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$9.71 - $25.11 $38,840 - $100,440
-4,000 Reduced 15.38%
22,000 $307,000
Q4 2019

Feb 14, 2020

BUY
$11.07 - $24.23 $287,820 - $629,980
26,000 New
26,000 $592,000

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $813M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.